You are here

Amgen

Amgen stock rises following FDA approval of Uplinza

Investing.com

Thu, 04/3/25 - 10:18 pm

immunoglobulin G4-related disease

How AZ and Amgen’s Tezspire respiratory data ups the ‘level of ambition’ in immunology

Pharma Voice

Thu, 03/27/25 - 11:06 am

chronic rhinosinusitis with nasal polyps

Amgen’s Uplizna deepens response against myasthenia gravis at 1 year

BioSpace

Thu, 03/13/25 - 11:28 am

myasthenia gravis

Amgen and Kyowa Kirin’s rocatinlimab trial for atopic dermatitis meets endpoints

Clinical Trials Arena

Mon, 03/10/25 - 09:34 am

clinical trials

atopic dermatitis

Amgen and CytomX throw off masked T-cell engager, axing asset after assessing data, priorities

Fierce Biotech

Fri, 03/7/25 - 11:09 am

CytomX Therapeutics

Amgen enters Maritime, launching 2 late-stage obesity trials for MariTide

Fierce Biotech

Wed, 03/5/25 - 10:58 pm

clinical trials

With patent losses on the horizon, Amgen refocuses its business strategy

Pharma Voice

Wed, 03/5/25 - 11:53 am

Amgen and AstraZeneca report results from Phase III trial of Tezspire for CRSwNP

Clinical Trials Arena

Mon, 03/3/25 - 10:19 am

clinical trials

chronic rhinosinusitis with nasal polyps

Amgen plans $200M investment in India site

Tip Ranks

Mon, 02/24/25 - 09:59 am

Amgen ends Ideaya cancer combination trial after partner unveils rival molecule

Fierce Biotech

Thu, 02/13/25 - 09:45 pm

IDEAYA Biosciences

With recent launches and more to come, Amgen's biosimilar business is trending up

Fierce Pharma

Thu, 02/6/25 - 11:43 am

Amgen's early-stage obesity asset slapped with FDA hold

Fierce Biotech

Wed, 02/5/25 - 11:27 am

clinical trials

Amgen Surpasses Q4 Earnings Forecasts

Motley Fool

Wed, 02/5/25 - 11:26 am

Amgen settles Prolia patent suit with Celltrion, teeing up potential biosimilar launch in June

Fierce Pharma

Wed, 01/29/25 - 11:20 am

FDA Approves Amgen's Groundbreaking LUMAKRAS Combination Therapy for Colorectal Cancer Treatment

Stock Titan

Fri, 01/17/25 - 11:21 am

metastatic colorectal cancer

HER-positive colorectal cancer

JP Morgan 2025: reduced dosing and expanded manufacturing paving way for Amgen’s obesity entrance

Clinical Trials Arena

Tue, 01/14/25 - 09:54 am

CytomX lays off 40% of staff, questions future of Amgen-partnered T-cell engager

Fierce Biotech

Tue, 01/7/25 - 11:14 am

CytomX Therapeutics

How pharma was instrumental in President Jimmy Carter’s global health efforts

Pharma Voice

Fri, 01/3/25 - 09:57 am

Viridian Stock Flashes A Bullish Sign In Its Eye-Disease Battle With Amgen

Investors Business Daily

Mon, 12/16/24 - 11:30 am

Viridian Therapeutics

thyroid eye disease

BeiGene inks $150M deal to follow cancer combo trail blazed by Amgen and Ideaya

Fierce Biotech

Fri, 12/13/24 - 11:41 am

Pages